GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 48 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $514,000 | +6.2% | 190,000 | -5.0% | 0.19% | +45.5% |
| Q4 2020 | $484,000 | +5.7% | 200,000 | 0.0% | 0.13% | -32.0% |
| Q3 2020 | $458,000 | -33.6% | 200,000 | -33.3% | 0.19% | -51.7% |
| Q2 2020 | $690,000 | +33.7% | 300,000 | 0.0% | 0.40% | +2.6% |
| Q1 2020 | $516,000 | -9.3% | 300,000 | +9.1% | 0.39% | +122.7% |
| Q4 2019 | $569,000 | -22.4% | 275,000 | +8.7% | 0.18% | -21.4% |
| Q3 2019 | $733,000 | +39.4% | 253,000 | +88.2% | 0.22% | +44.5% |
| Q2 2019 | $526,000 | – | 134,400 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,765,901 | $4,273,000 | 2.32% |
| NEA Management Company, LLC | 10,376,936 | $25,112,000 | 0.66% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $478,000 | 0.62% |
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $908,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $4,772,000 | 0.52% |
| BVF INC/IL | 4,012,404 | $9,710,000 | 0.38% |
| Avoro Capital Advisors LLC | 5,084,184 | $12,304,000 | 0.21% |
| FNY Investment Advisers, LLC | 200,000 | $484,000 | 0.13% |
| Boxer Capital, LLC | 1,134,453 | $2,745,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,745 | $316,000 | 0.05% |